Redsense Medical AB

REDS

SE0006965158

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 27/06/2024 am IST			5-day change	1st Jan Change
7 ^SEK	+2.94%		-7.89%	-7.89%

28/05	Redsense Medical CEO to Step Down; CFO Named as Acting CEO	MT
27/05	Redsense Medical’s CEO Steps Down	MT

Redsense Medical AB Appoints Dr. Maria Alquist to the Board of Directors

August 26, 2019 at 12:00 pm IST

Redsense Medical AB (publ) appointed Dr. Maria Alquist to the Board of Directors.

Latest news about Redsense Medical AB

Redsense Medical CEO to Step Down; CFO Named as Acting CEO	28/05	MT
Redsense Medical’s CEO Steps Down	27/05	MT
Redsense Medical AB Announces CEO Changes	27/05	CI
Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Redsense Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/02	CI
Redsense Medical Late Board Chair's Company to Retain Shares	06/02	MT
Redsense Medical Appoints Eva Walde as Chairman of Board of Directors	09/01	CI
Redsense Medical Announces Demise of Patrik Byhmer as Chairman of the Board	23/12	CI
Redsense Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Redsense Medical AB Announces Nomination Committee Appointed for the 2024 Annual General Meeting	26/23/26	CI
Redsense Medical to Start Trading on US OTCQX Platform	29/23/29	MT
Redsense Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Redsense Medical AB Secures New Order of SEK 11.2 Million	15/23/15	CI
Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	09/23/09	CI
Redsense Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	27/23/27	CI
Redsense Medical AB Announces Appointment of Jennie Kardell as Chief Financial Officer, Effective March 2023	20/23/20	CI
Redsense Medical Announces Partial Delivery of Record Order	03/23/03	CI
Redsense Medical Secures New Order Valued at SEK 15.2 Million from One of the Company's US Distributors	02/22/02	CI
Redsense Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Redsense Medical AB Receives Order from One of the Company's US Distributors	18/22/18	CI
Redsense Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	29/22/29	CI
Redsense Medical AB Appoints Patrik Byhmer as Chairman of the Board	06/22/06	CI
Redsense Medical Announces CEO Changes	06/22/06	CI
Redsense Medical AB Announces CEO Changes	02/22/02	CI
Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2022	02/22/02	CI

Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.

Sector

Medical Equipment, Supplies & Distribution

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
REDSENSE MEDICAL AB	-7.89%	92.51L
BIOMÉRIEUX	-11.78%	1.14TCr
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-13.76%	739.82Cr
LANTHEUS HOLDINGS, INC.	+29.50%	563.58Cr
DIASORIN S.P.A.	-0.19%	533.25Cr
AUTOBIO DIAGNOSTICS CO., LTD.	-19.19%	370.26Cr
ANDON HEALTH CO., LTD.	+7.62%	257.78Cr
10X GENOMICS, INC.	-65.24%	237.62Cr
VITROLIFE AB	-10.48%	220.46Cr
MYRIAD GENETICS, INC.	+27.80%	220.02Cr

Diagnostic & Testing Substances